Page last updated: 2024-08-18

2-aminopyrimidine and Ovarian Neoplasms

2-aminopyrimidine has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arvanitis, C; Chen, L; Condello, S; Grigorescu, AA; Matei, D; Nwani, NG; Schiltz, GE; Sima, LE; Yakubov, B; Zhang, S; Zhang, ZY	1

Other Studies

1 other study(ies) available for 2-aminopyrimidine and Ovarian Neoplasms

Article	Year
Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin. Molecular cancer therapeutics, 2019, Volume: 18, Issue:6 Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Female; Fibronectins; Focal Adhesion Kinase 1; GTP-Binding Proteins; Humans; Integrin beta1; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Ovarian Neoplasms; Paclitaxel; Protein Binding; Protein Glutamine gamma Glutamyltransferase 2; Pyrimidines; Signal Transduction; Transglutaminases; Xenograft Model Antitumor Assays	2019

Article

Year

Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.

Molecular cancer therapeutics, 2019, Volume: 18, Issue:6

Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Female; Fibronectins; Focal Adhesion Kinase 1; GTP-Binding Proteins; Humans; Integrin beta1; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Ovarian Neoplasms; Paclitaxel; Protein Binding; Protein Glutamine gamma Glutamyltransferase 2; Pyrimidines; Signal Transduction; Transglutaminases; Xenograft Model Antitumor Assays

2019